What is the management of acute asthma in pediatrics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Asthma in Pediatrics

Immediately administer high-flow oxygen via face mask, nebulized salbutamol 5 mg (or 2.5 mg in very young children), and oral prednisolone 1-2 mg/kg (maximum 40 mg) within the first few minutes of presentation for any child with acute severe asthma. 1, 2

Initial Assessment and Recognition

Recognize acute severe asthma in children by the following clinical features:

  • Too breathless to talk or feed 1
  • Respiratory rate >50 breaths/minute 1
  • Heart rate >140 beats/minute 1
  • Peak expiratory flow (PEF) <50% predicted (if measurable in children ≥5 years) 1

Life-threatening features requiring immediate aggressive intervention include:

  • PEF <33% predicted or poor respiratory effort 1
  • Silent chest, cyanosis, or fatigue/exhaustion 1
  • Agitation or reduced level of consciousness 1

Critical pitfall: Children with severe attacks may not appear distressed, and assessment in very young children may be difficult—the presence of any single feature should alert you to severity. 1

Immediate Treatment Protocol (First 15-30 Minutes)

Oxygen Therapy

  • Administer high-flow oxygen (40-60%) via face mask immediately 1, 2, 3
  • Maintain oxygen saturation >92% with continuous pulse oximetry 1, 2
  • CO2 retention is not aggravated by oxygen therapy in asthma 1

Bronchodilator Therapy

Nebulized beta-agonist is the primary bronchodilator:

  • Salbutamol 5 mg via oxygen-driven nebulizer (use 2.5 mg in very young children) 1, 2, 3
  • Alternative: Terbutaline 10 mg via nebulizer (5 mg in very young children) 1, 3

Alternative delivery method with equivalent efficacy:

  • Metered-dose inhaler (MDI) with large volume spacer: 1 puff every few seconds up to 10-20 puffs maximum 1, 2
  • Use a face mask with the spacer in very young children 1
  • This method is supported by high-quality evidence showing comparable efficacy to nebulization with shorter treatment times and fewer adverse effects 4, 5

Systemic Corticosteroids

Administer corticosteroids immediately—do not delay:

  • Oral prednisolone 1-2 mg/kg body weight (maximum 40 mg) 1, 2, 3
  • If child is vomiting or severely ill: Intravenous hydrocortisone 200 mg 1, 2

Anticholinergic Therapy

  • Add ipratropium 100 mcg (0.1 mg) to nebulizer, repeat every 6 hours 1, 3
  • Can be mixed in the same nebulizer with salbutamol 2

Reassessment at 15-30 Minutes

Measure and document the following:

  • Peak expiratory flow rate (if appropriate for age) 1, 2
  • Oxygen saturation 1, 2
  • Respiratory rate and heart rate 2
  • Clinical appearance and work of breathing 2

If Patient is Improving:

  • Continue high-flow oxygen 1
  • Continue prednisolone 1-2 mg/kg daily (maximum 40 mg) 1
  • Continue nebulized beta-agonist every 4 hours 1

If Patient is NOT Improving:

  • Continue oxygen and steroids 1
  • Increase nebulized beta-agonist frequency to every 15-30 minutes 1, 2
  • Continue ipratropium every 6 hours until improvement begins 1
  • Consider continuous nebulization 2

Life-Threatening Features: Additional Management

If life-threatening features are present, add:

  • Intravenous aminophylline: 5 mg/kg loading dose over 20 minutes, followed by 1 mg/kg/hour maintenance infusion 1
  • Critical caveat: Omit the loading dose if the child is already receiving oral theophyllines 1

Monitoring Throughout Treatment

Continuous monitoring includes:

  • Pulse oximetry to maintain SaO2 >92% 1, 2, 3
  • Chart PEF before and after each beta-agonist administration and at least 4 times daily 1, 3
  • Respiratory rate and heart rate 2
  • Clinical assessment of work of breathing and mental status 2

Blood gas measurements are rarely helpful in deciding initial management in children. 1

Critical Pitfalls to Avoid

  • Never give sedatives of any kind—they can precipitate respiratory failure 1, 2
  • Do not delay systemic corticosteroids—they should be given immediately 2
  • Do not underestimate severity—children may not appear distressed despite severe obstruction 1
  • Avoid inadequate oxygen delivery—use high-flow systems 2

Criteria for ICU Transfer

Transfer to intensive care unit if:

  • Deteriorating PEF despite treatment 1, 2
  • Worsening or persistent hypoxia 1, 2
  • Exhaustion, feeble respirations, confusion, or drowsiness 1, 2
  • Coma or respiratory arrest 1

The patient should be accompanied by a physician prepared to intubate. 1

Discharge Criteria

Before discharge, ensure:

  • Patient has been on discharge medication for 24 hours 1, 3
  • Inhaler technique has been checked and recorded 1, 3
  • PEF >75% of predicted or best (if measurable) 1, 3
  • PEF diurnal variability <25% 1, 3
  • Treatment plan includes oral corticosteroids (continue for 3-5 days), inhaled corticosteroids, and bronchodilators 1, 3
  • Written self-management plan provided 1
  • GP follow-up arranged within 1 week 1
  • Respiratory clinic follow-up within 4 weeks 1

Evidence Considerations

The British Thoracic Society guidelines provide the foundational framework for pediatric acute asthma management. 1 Recent meta-analyses demonstrate that MDI with spacer is equally effective as nebulization, with advantages including shorter treatment times (66 vs 103 minutes), fewer episodes of vomiting (9% vs 20%), and smaller increases in heart rate. 4, 5 However, nebulizers remain the standard in most emergency settings and are explicitly recommended in the guidelines. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Immediate Treatment for Severe Asthma in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nebulization Guidelines for Pediatric Patients with Acute Asthma in the ER

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metered-dose inhalers with spacers vs nebulizers for pediatric asthma.

Archives of pediatrics & adolescent medicine, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.